Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
gene therapy
9
×
life sciences
9
×
national blog main
national top stories
boston blog main
boston top stories
national
new york blog main
new york top stories
biotech
clinical trials
deals
hemophilia
novartis
san francisco blog main
san francisco top stories
spark therapeutics
fda
zolgensma
car-t
pfizer
san diego blog main
san diego top stories
sangamo therapeutics
spinal muscular atrophy
vc
alnylam pharmaceuticals
biogen
biomarin pharmaceutical
bluebird bio
boulder/denver blog main
boulder/denver top stories
cancer
crispr
detroit blog main
detroit top stories
genentech
harvard pilgrim health care
indiana blog main
indiana top stories
What
therapy
9
×
gene
fda
patients
aren’t
bio
car
cutting
drug
edge
help
long
market
medicine
moves
new
past
roundup
science
access
advanced
age
approved
atrophy
becker
bigger
biggest
billions
capacity
cell
chemistry
close
cmc
come
consistent
consolidation
controls
crispr
crude
daily
Language
unset
Current search:
therapy
×
" life sciences "
×
" gene therapy "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
FDA Official: New “Playbook” Needed for CMC Reviews of Gene Therapy Products
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”